We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
-2.06%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$223M
AUM Growth
+$3.45M
Cap. Flow
+$9.56M
Cap. Flow %
4.28%
Top 10 Hldgs %
47.78%
Holding
155
New
14
Increased
32
Reduced
14
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 27.7%
2 Energy 21.34%
3 Financials 6.81%
4 Materials 3.65%
5 Technology 3.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTXS
126
DELISTED
Citrix Systems Inc
CTXS
$247K 0.11%
+4,415
New +$235K
NVS icon
127
Novartis
NVS
$297B
$246K 0.11%
2,790
STRZA
128
DELISTED
Starz - Series A
STRZA
$245K 0.11%
+5,475
New +$218K
PGEN icon
129
Precigen
PGEN
$2.53B
$244K 0.11%
5,045
-187
-4% -$7.88K
IMGN
130
DELISTED
Immunogen Inc
IMGN
$244K 0.11%
+16,985
New +$187K
T icon
131
AT&T
T
$164B
$243K 0.11%
9,076
MMM icon
132
3M
MMM
$93.8B
$235K 0.11%
1,818
WDC icon
133
Western Digital
WDC
$153B
$235K 0.11%
3,969
MRK icon
134
Merck
MRK
$322B
$234K 0.1%
4,302
VXUS icon
135
Vanguard Total International Stock ETF
VXUS
$162B
$232K 0.1%
4,600
+600
+15% +$31.5K
WBA
136
DELISTED
Walgreens Boots Alliance
WBA
$227K 0.1%
2,693
IONS icon
137
Ionis Pharmaceuticals
IONS
$9.53B
$220K 0.1%
3,817
NOV icon
138
NOV
NOV
$7.34B
$220K 0.1%
+4,562
New +$235K
IWF icon
139
iShares Russell 1000 Growth ETF
IWF
$127B
$218K 0.1%
8,816
SJM icon
140
J.M. Smucker
SJM
$12.6B
$217K 0.1%
2,000
QVCGA
141
DELISTED
QVC Group Inc Series A
QVCGA
$217K 0.1%
161
FCX icon
142
Freeport-McMoran
FCX
$99.1B
$216K 0.1%
11,586
-100
-0.9% -$2.06K
RYAAY icon
143
Ryanair
RYAAY
$30.9B
$214K 0.1%
7,312
JCI icon
144
Johnson Controls International
JCI
$91.7B
$213K 0.1%
4,106
MON
145
DELISTED
Monsanto Co
MON
$213K 0.1%
2,000
ACWI icon
146
iShares MSCI ACWI ETF
ACWI
$33.3B
$202K 0.09%
+3,400
New +$210K
DAR icon
147
Darling Ingredients
DAR
$9.98B
$147K 0.07%
10,000
DARE icon
148
Dare Bioscience
DARE
$20.4M
$92K 0.04%
167
IRD
149
Opus Genetics
IRD
$308M
$91K 0.04%
313
VIRX
150
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$33K 0.01%
52

Similar funds

Northeast Financial Consultants's Q2 2015 Portfolio in Review

As of Q2 2015, Northeast Financial Consultants held 155 positions worth $223M, up 1.6% from $220M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Northeast Financial Consultants deployed $9.56M of net new capital in Q2 2015, opening 14 new positions and adding to 32 existing holdings. Its largest new stake was Vanguard Morningstar Small-Cap Value ETF: 13,035 shares worth $1.41M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was Apple, an estimated $838K trimmed.

  • Northeast Financial Consultants's largest Q2 2015 buy was Vanguard Morningstar Small-Cap Value ETF: 13,035 shares worth $1.41M.
  • Northeast Financial Consultants added most to Vanguard Morningstar Total Stock Market ETF in Q2 2015, an estimated $2.27M increase.
  • Northeast Financial Consultants's biggest Q2 2015 reduction was Apple, cutting an estimated $838K.
  • Northeast Financial Consultants fully exited iShares Biotechnology ETF in Q2 2015, selling an estimated $1.34M.
  • Northeast Financial Consultants's ten largest holdings make up 48% of its $223M portfolio in Q2 2015.
  • Northeast Financial Consultants opened 14 new positions and closed 5 in Q2 2015.
  • Northeast Financial Consultants's portfolio value rose 1.6% quarter-over-quarter to $223M.

Based on Northeast Financial Consultants's 13F filing for Q2 2015, filed 13 Aug 2015.